Sort
261,768 grants matching “gene therapy”
Transformative research on somatic gene recombination in the normal and Alzheimer's disease-related dementia brain
$924,514Jerold Chun · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · AG
Transformative research on somatic gene recombination in the normal and Alzheimer's disease-related dementia brain
$924,514Jerold Chun · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · AG
Transformative research on somatic gene recombination in the normal and Alzheimer's disease-related dementia brain
$924,514Jerold Chun · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AG
Role of NLRP3 signals in ischemia/reperfusion-induced organ injury
$924,366Dianne B McKay · Scripps Research Institute, The · R01 · FY2022 · DK
GENE TRANSFER TO THE NERVOUS SYSTEM
$924,319University Of Florida · P01 · FY2002 · NS
Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy
$924,309Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R35 · FY2021 · CA
Metabolic Regulators of Tumor Growth and Progression
$924,299Ralph J Deberardinis · Ut Southwestern Medical Center · R35 · FY2022 · CA
Dermatology Consultation Service
$924,248Edward Cowen · Division Of Basic Sciences - Nci · ZID · FY2012 · CA
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder
$924,239Timothy A Benke · University Of Colorado Denver · U01 · FY2022 · NS
Epigenetic mechanisms regulating the Igf2/H19 and Kcnq1 locus
$924,196Karl Eric Pfeifer · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD
Core Center for Stem Cell and Transplantation Biology
$924,185Beverly J Torok-Storb · Fred Hutchinson Cancer Research Center · U54 · FY2018 · DK
HIV Persistence During Suppressive Antiretroviral Therapy
$924,183Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
HLA-G at the Maternal Fetal Interface
$924,095Margaret G Petroff · University Of Kansas Medical Center · P01 · FY2011 · HD
Angiotensin Analogs to Treat Wound Healing
$924,089Kathleen E. Rodgers · Us Biotest, Inc. · R44 · FY2007 · DK
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
$924,071Ronald Levy · Stanford University · R35 · FY2016 · CA
Targeting DNA damage response pathways for the treatment of advanced lung cancer
$924,071Diane S Keeney · Cumberland Pharmaceuticals, Inc. · R44 · FY2018 · CA
The role of osteoblast progenitors in response to bone anabolic agents
$924,044Henry M Kronenberg · Massachusetts General Hospital · P50 · FY2023 · AR
Genome Sequencing to identify novel genetic factors for breast cancer risk
$924,034Wei Zheng · Vanderbilt University · R01 · FY2012 · CA
National Gene Vector Biorepository and Coordinating Center at Indiana University
$924,033Kenneth G Cornetta · Indiana University Indianapolis · P40 · FY2015 · HL
Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation
$924,000Robert Jon Soiffer · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Signal Transduction Events and the Regulation of Cell Growth
$923,994Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2019 · CA
TDP-43 aggregation inhibitors for the treatment of ALS
$923,960Glenn Larsen · Aquinnah Pharmaceuticals, Inc. · R44 · FY2018 · NS
Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology
$923,949David G Kirsch · Duke University · R35 · FY2022 · CA
Specificity and regulation TCR pathway protein tyrosine kinases and phosphatases
$923,940Arthur Weiss · University Of California, San Francisco · P01 · FY2015 · AI
Cyclin-dependent kinase 5 (Cdk5) in Physiology and Pathology
$923,936Harish C Pant · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS